Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
5
×
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
5
×
life sciences
national
5
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
fda
pfizer
biotech ipos
eli lilly
merck
messenger rna
nivolumab
startups
What
bio
roundup
drug
companies
growing
new
week
advantages
alliance
alzheimer’s
annual
approved
assessed
attention
bar
biotech
biotechs
brings
bristol
buy
calls
changing
club
color
communities
conference
continued
crispr
crop
days
digital
disease
epidemic
esmo
europe
exceeded
expect
fatty
fda
firms
Language
unset
Current search:
investing
×
national
×
" bristol-myers squibb "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
